GILD
Gilead Sciences, Inc.
- Depreciation and amortization, 2025
- $2.8B
- YoY, 2025
- −0.3%
- 5-year CAGR
- +13.3%
- 10-year CAGR
- +9.7%
Depreciation and amortization
Depreciation and amortization by fiscal year
| Period | D&A | YoY |
|---|---|---|
| 2025 | $2.8B | −0.3% |
| 2024 | $2.8B | +2.7% |
| 2023 | $2.7B | +28.1% |
| 2022 | $2.1B | +2.6% |
| 2021 | $2.1B | +38.5% |
| 2020 | $1.5B | +5.4% |
| 2019 | $1.4B | −1.7% |
| 2018 | $1.4B | +11.1% |
| 2017 | $1.3B | +11.1% |
| 2016 | $1.2B | +5.5% |
| 2015 | $1.1B | +4.6% |
| 2014 | $1.1B | +204.3% |
| 2013 | $345M | +24.1% |
| 2012 | $278M | −8.0% |
| 2011 | $302M | +13.8% |
| 2010 | $265M | +24.7% |
| 2009 | $213M | +36.8% |
| 2008 | $156M | +53.5% |
| 2007 | $101M | — |